Glioblastoma endothelium drives bevacizumab ‐induced infiltrative growth via modulation of PLXDC1

This study indicates that bevacizumab‐induced brain infiltration is driven by vascular endothelium and depends on PLXDC1 activation of tumor cells.This article is protected by copyright. All rights reserved.

Source: International Journal of Cancer - November 10, 2018 Category: Cancer & Oncology Authors: Maria Laura Falchetti, Quintino Giorgio D'Alessandris, Simone Pacioni, Mariachiara Buccarelli, Liliana Morgante, Stefano Giannetti, Valentina Lulli, Maurizio Martini, Luigi Maria Larocca, Eliza Vakana, Louis Stancato, Lucia Ricci ‐Vitiani, R Tags: Research Article Source Type: research